H. Dyer

FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism

D. Hirst, H. McCarthy, D. Waugh, 2011, Clinical Cancer Research.

Cancer Therapy : Preclinical FKBPL and Peptide Derivatives : Novel Biological Agents That Inhibit Angiogenesis by a CD 44-Dependent Mechanism

D. Hirst, H. McCarthy, D. Waugh, 2011 .

That Inhibit Angiogenesis by a CD 44-Dependent Mechanism FKBPL and Peptide Derivatives : Novel Biological Agents

D. Hirst, H. McCarthy, D. Waugh, 2011 .

The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway

D. Hirst, H. McCarthy, L. McClements, 2013, PloS one.